Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aspire Biopharma Holdings Inc.

0.3805
+0.040511.91%
Post-market: 0.38100.0005+0.13%19:59 EDT
Volume:2.61M
Turnover:943.71K
Market Cap:18.84M
PE:-1.09
High:0.3880
Open:0.3348
Low:0.3300
Close:0.3400
Loading ...
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Apr 19, 2025

Correspondence

Form CORRESP - Correspondence
Apr 18, 2025

Major Issues Report

Form 8-K - Current report
Apr 09, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 07, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 23, 2024

Correspondence

Form CORRESP - Correspondence
Dec 10, 2024

Correspondence

Form CORRESP - Correspondence
Nov 15, 2024

Correspondence

Form CORRESP - Correspondence
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 24, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Oct 24, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Oct 24, 2024

Correspondence

Form CORRESP - Correspondence
Oct 23, 2024

Correspondence

Form CORRESP - Correspondence
Oct 10, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 10, 2024

Major Issues Report

Form 8-K - Current report
Oct 04, 2024

Major Issues Report

Form 8-K - Current report
Oct 04, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Sep 06, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations